Crossmark

Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review

Published Online: 2021-04-23

Published Print: 2021-12

Authors

Trac, Judy

Keck, J. Myles

Deweese, Joseph E. http://orcid.org/0000-0001-9683-6723
Funding

Funding for this research was provided by:

College of Pharmacy and Health Sciences, Lipscomb University
License Information

Text and Data Mining valid from 2021-04-23

Version of Record valid from 2021-04-23
More Information

Article History

Received: 5 May 2020

Accepted: 13 April 2021

First Online: 23 April 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current